{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:02:58Z","timestamp":1791669778871,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaip.2022.05.041","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T02:20:49Z","timestamp":1655950849000},"page":"2588-2595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9708-3241","authenticated-orcid":false,"given":"Andriana I.","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Fouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tzanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Antoniou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Samitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Zervas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Kostikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Bartziokas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Porpodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despoina","family":"Papakosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argyris","family":"Tzouvelekis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irini","family":"Gerogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Kotsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Makris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoletta","family":"Rovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyfallia","family":"Vlachou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Markatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Vittorakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Afthinos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Katsaounou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paschalis","family":"Steiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Latsios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dimakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Koukidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Hillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Tryfon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kallieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Georgopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Avarlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Markopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Gaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimina","family":"Paspala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zacharoula","family":"Kyriakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridon","family":"Papiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stelios","family":"Loukides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2022.05.041_bib1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A\u00a0novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J\u00a0Neuroimmune Pharmacol"},{"key":"10.1016\/j.jaip.2022.05.041_bib3","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2022.05.041_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228544","article-title":"Prevalence and contribution of respiratory viruses in the community to rates of emergency department visits and hospitalizations with respiratory tract infections, chronic obstructive pulmonary disease and asthma","volume":"15","author":"Satia","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.jaip.2022.05.041_bib5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(10)61380-3","article-title":"Role of viral respiratory infections in asthma and asthma exacerbations","volume":"376","author":"Busse","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.05.041_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02226-2020","article-title":"Effect of asthma and asthma medication on the prognosis of patients with COVID-19","volume":"57","author":"Choi","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib7","article-title":"Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy","volume":"177","author":"Eger","year":"2020","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03142-2020","article-title":"The impact of COVID-19 on patients with asthma","volume":"57","author":"Izquierdo","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaci.2020.05.049","article-title":"Asthmatic patients in COVID-19 outbreak: few cases despite many cases","volume":"146","author":"Caminati","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01875-2020","article-title":"Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation","volume":"56","author":"Beurnier","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03045-2020","article-title":"Why asthma might surprisingly protect against poor outcomes in COVID-19","volume":"56","author":"Farne","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib12","article-title":"Asthma does not increase COVID-19 mortality and poor outcomes: a systematic review and meta-analysis","author":"Soeroto","year":"2021","journal-title":"Asian Pac J Allergy Immunol. Published online April 18"},{"key":"10.1016\/j.jaip.2022.05.041_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.anai.2021.02.023","article-title":"The evidence is in that asthma is not associated with severe coronavirus disease 2019","volume":"126","author":"Timberlake","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib14","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.2500\/aap.2021.42.200125","article-title":"COVID-19 in a patient with severe asthma using mepolizumab","volume":"42","author":"Aksu","year":"2021","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2022.05.041_bib15","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.anai.2021.01.006","article-title":"Severe acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy","volume":"126","author":"Azim","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/all.14534","article-title":"Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology","volume":"76","author":"Bhalla","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.041_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.anai.2020.06.012","article-title":"COVID-19, severe asthma, and biologics","volume":"125","author":"Garc\u00eda-Moguel","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib18","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1111\/all.14456","article-title":"COVID-19 in a patient with severe asthma treated with Omalizumab","volume":"75","author":"Lommatzsch","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.041_bib19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1080\/02770903.2020.1781165","article-title":"COVID-19 in a severe eosinophilic asthmatic receiving benralizumab\u2014a case study","volume":"58","author":"Renner","year":"2021","journal-title":"J\u00a0Asthma"},{"key":"10.1016\/j.jaip.2022.05.041_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jaci.2021.06.006","article-title":"COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence","volume":"148","author":"Adir","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib21","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jaip.2020.09.050","article-title":"Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak","volume":"9","author":"Rial","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.041_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib23","article-title":"GINA workshop report, global strategy for asthma management and prevention","author":"Global Initiative for Asthma","year":"2020","journal-title":"Revised"},{"key":"10.1016\/j.jaip.2022.05.041_bib24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/all.14532","article-title":"COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments","volume":"76","author":"Heffler","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.041_bib25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/all.14516","article-title":"COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey","volume":"76","author":"Matucci","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2022.05.041_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ccm.2016.11.014","article-title":"Respiratory viral infections in chronic lung diseases","volume":"38","author":"Britto","year":"2017","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04493-2020","article-title":"Reduction in asthma admissions during the COVID-19 pandemic: consequence of public health measures in Singapore","volume":"57","author":"Wee","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib28","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(21)00013-8","article-title":"Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK","volume":"9","author":"Bloom","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(21)01744-X","article-title":"Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial","volume":"398","author":"Yu","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2022.05.041_bib31","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jaci.2020.04.061","article-title":"Prevalence of comorbid asthma in COVID-19 patients","volume":"146","author":"Butler","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib32","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of COVID-19 in New York City","volume":"382","author":"Goyal","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2022.05.041_bib33","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02857-2020","article-title":"COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry","volume":"56","author":"Hanon","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2022.05.041_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/vim.2018.0150","article-title":"Eosinophils and respiratory viruses","volume":"32","author":"Flores-Torres","year":"2019","journal-title":"Viral Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.622554","article-title":"Anti-IL5 drugs in COVID-19 patients: role of eosinophils in SARS-CoV-2-induced immunopathology","volume":"12","author":"Pala","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2022.05.041_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2022.05.041_bib37","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1016\/S2352-3026(20)30217-9","article-title":"Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study","volume":"7","author":"Liao","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jaip.2022.05.041_bib38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1080\/00365513.2020.1768587","article-title":"Laboratory findings of COVID-19: a systematic review and meta-analysis","volume":"80","author":"Zhang","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.jaip.2022.05.041_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40364-020-00217-0","article-title":"A\u00a0meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19)","volume":"8","author":"Danwang","year":"2020","journal-title":"Biomark Res"},{"key":"10.1016\/j.jaip.2022.05.041_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40001-020-00432-3","article-title":"Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis","volume":"25","author":"Ghahramani","year":"2020","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jaip.2022.05.041_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102473","article-title":"Characteristics and prognostic factors of disease severity in patients with COVID-19: the Beijing experience","volume":"112","author":"Sun","year":"2020","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.jaip.2022.05.041_bib42","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jaip.2020.12.045","article-title":"Eosinophilia in asthma patients is protective against severe COVID-19 illness","volume":"9","author":"Ferastraoaru","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.041_bib43","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.jaip.2020.12.033","article-title":"Type 2 asthma inflammation and COVID-19: a double edged sword","volume":"9","author":"Lipworth","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.041_bib44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jaci.2020.04.009","article-title":"Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2","volume":"146","author":"Jackson","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib45","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1365-2222.2008.02954.x","article-title":"Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9","volume":"38","author":"Tversky","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2022.05.041_bib46","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/thoraxjnl-2013-203738","article-title":"Against all odds: anti-IgE for intrinsic asthma?","volume":"69","author":"Lommatzsch","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2022.05.041_bib47","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jaci.2020.09.017","article-title":"Asthma-associated risk for COVID-19 development","volume":"146","author":"Skevaki","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2022.05.041_bib48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3390\/biomedicines9040348","article-title":"Immunological aspects related to viral infections in severe asthma and the role of omalizumab","volume":"9","author":"Menzella","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2022.05.041_bib49","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.jaip.2020.09.015","article-title":"Asthma disparities during the COVID-19 pandemic: a survey of patients and physicians","volume":"8","author":"Baptist","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2022.05.041_bib50","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1016\/j.jaip.2021.07.030","article-title":"Asthma disease status, COPD, and COVID-19 severity in a large multiethnic population","volume":"9","author":"Huang","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822006110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219822006110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:35:15Z","timestamp":1761975315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219822006110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2213219822006110"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2022.05.041","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SARS-Cov-2 Infection in Severe Asthma Patients Treated With Biologics","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2022.05.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}